Drug
NEPA
NEPA is a pharmaceutical drug with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph phase_2
1
33%
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
Phase 4Post-market surveillance
1(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Active, not recruiting1
Recruiting1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 21 (50.0%)
Phase 41 (50.0%)
Trials by Status
active_not_recruiting133%
recruiting133%
not_yet_recruiting133%
Recent Activity
2 active trials
Showing 3 of 3
active_not_recruitingphase_2
AKY15-HK-301_NEPA Study
NCT03386617
not_yet_recruitingphase_4
A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients
NCT07254416
recruiting
The Safety and Effectiveness of NEPA in Preventing Postoperative Nausea and Vomiting After General Anesthesia Gastrointestinal Cancer Surgery: A Single-Center Retrospective Study
NCT06417567
Clinical Trials (3)
Showing 3 of 3 trials
NCT03386617Phase 2
AKY15-HK-301_NEPA Study
NCT07254416Phase 4
A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients
NCT06417567
The Safety and Effectiveness of NEPA in Preventing Postoperative Nausea and Vomiting After General Anesthesia Gastrointestinal Cancer Surgery: A Single-Center Retrospective Study
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3